Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compounds, formulations, and methods for treating or preventing rosacea

a technology for rosacea and rosacea gel, applied in the field of compound and method for treating or preventing rosacea, can solve the problem that the skin cannot penetrate in sufficient amounts to induce serious systemic side effects, and achieve the effect of ameliorating reducing the symptoms of rosacea

Inactive Publication Date: 2006-08-03
GALDERMA LAB LP
View PDF5 Cites 59 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The compounds are delivered in a topical skin composition that insures that the compounds are effective in the skin of a patient but do not penetrate the skin in sufficient amounts to induce serious systemic side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds, formulations, and methods for treating or preventing rosacea
  • Compounds, formulations, and methods for treating or preventing rosacea
  • Compounds, formulations, and methods for treating or preventing rosacea

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

1.1 COMPOUNDS OF THE INVENTION

[0019] In one embodiment, the invention is directed to compounds of the Formula I:

[0020] wherein each of R1, R2, and R3 is independently hydrogen, halogen, alkyl, preferably, unsubstituted alkyl, or alkoxy, preferably, unsubstituted alkoxy; each of R4 and R5 is independently hydrogen, alkyl, preferably, unsubstituted alkyl, or alkoxy, preferably, unsubstituted alkoxy; and each of R6 and R7 is independently hydrogen, nitro, alkyl, preferably, unsubstituted alkyl, or alkoxy, preferably, unsubstituted alkoxy. In a preferred embodiment of the compounds of Formula I, R6 and R7 are both hydrogen. In another preferred embodiment, R4 and R5 are both hydrogen.

[0021] In another embodiment, the invention is directed to compounds of the Formula Ia;

[0022] wherein each of R1, R2, and R3 is independently hydrogen, halogen, alkyl, preferably, unsubstituted alkyl, or alkoxy, preferably, unsubstituted alkoxy; each of R4 and R5 is independently hydrogen, alkyl, pref...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
weight percentaaaaaaaaaa
weight percentaaaaaaaaaa
Login to View More

Abstract

In methods, compounds, and topical formulations for treatment of rosacea incorporating compounds represented by the formulas below: wherein each of R1, R2, and R3 is independently hydrogen, hologen, alkyl, or alkoxy; each of R4 and R5 is independently hydrogen, alkyl, or alkoxy; and each of R6 and R7 is independently hydrogen, nitro, alkyl, or alkoxy; wherein each of A1, A3, and A4 is independently hydrogen or alkyl; and A2 is independently hydrogen or hydroxy; and wherein each of B1, B2, and B3 is independently hydrogen, hydroxy, or alkoxy; and each of B4 and B5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat rosacea and its symptoms.

Description

CROSS REFERENCE TO RELATED APPLICATION [0001] This application is a continuation of U.S. patent application Ser. No. 10 / 853,585, filed May 25, 2004, which in turn claims priority from U.S. Patent Application Ser. No. 60 / 473,611, filed on May 27, 2003, both of which are incorporated herein by reference.FIELD OF THE INVENTION [0002] The present invention is directed to compounds and methods for treatment or prevention of rosacea. The compounds and methods taught by the present invention are particularly useful for treating or preventing rosacea and the symptoms of rosacea. BACKGROUND OF THE INVENTION [0003] Many people are affected by inflammatory skin disorders that result in unsightly and painful rashes, acne, persistent red veins, and acne-like skin eruptions, such as macules, nodules, and pustules that may ooze or crust. Inflammatory skin disorders often result in intense psychosocial distress. Rosacea is a common inflammatory skin disorder affecting over 10 million people in the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/498A61K31/4164A61K31/137A61K31/00A61K45/06
CPCA61K31/00A61K31/137A61K31/4164A61K31/498A61K31/4174A61K45/06A61K2300/00A61P17/00A61P17/10A61P29/00A61P7/10A61P9/00Y02A50/30A61K9/0014A61K9/06
Inventor DEJOVIN, JACKROSSI, THOMAS M.
Owner GALDERMA LAB LP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com